Canada: No Need To Speculate: Ontario Court Of Appeal Affirms Denial Of Certification In Pharmaceutical Product Liability Class Action Based On Increased Risk Of Harm - Cassels

Credit: Mondaq- Published on April 24, 2024
Can consumers subject to an increased risk of harm from a product successfully certify a product liability class action even though the harm has not yet, and may never...
👓 View full article:  

You are here

› Legal › Canada: No Need To Speculate: Ontario Court Of Appeal Affirms Denial Of Certification In Pharmaceutical Product Liability Class Action Based On Increased Risk Of Harm - Cassels

Related videos from verified sources

Norfolk Southern Offers Settlement to Resolve Lawsuits Related to 2023 Derailment 01:31
Credit: Wibbitz Top Stories - Published on April 9, 2024 


Related news from verified sources

Canada: Court Of Appeal Upholds Certification Denial And Dismissal Of Drug Recall Class Action - Osler, Hoskin & Harcourt LLP
The Court of Appeal for Ontario released its decision yesterday in Palmer v. Teva Canada Limited, affirming the denial of certification and dismissal of a...
on April 5, 2024 • Mondaq

You might like

© 2024 newsR Ltd.
All Rights Reserved.

Contact us





Video

🔝 Scroll back up to the top

⌂ Home Page

Desktop version of this page:
🖥️ Canada: No Need To Speculate: Ontario Court Of Appeal Affirms Denial Of Certification In Pharmaceutical Product Liability Class Action Based On Increased Risk Of Harm - Cassels